Press release content from BusinessWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Global Enteral Feeding Devices Market Outlook to 2025 - ResearchAndMarkets.com

August 8, 2018

DUBLIN--(BUSINESS WIRE)--Aug 8, 2018--The “Enteral Feeding Devices Market by Product, Age Group, Application and End User - Global Opportunity Analysis and Industry Forecast, 2018-2025” report has been added to ResearchAndMarkets.com’s offering.

The market was valued at $2,503 million in 2017, and is projected to reach $3,848 million by 2025 at a CAGR of 5.4% from 2018 to 2025.

Increase in prevalence of several chronic disorders such as cancer, neurological disorders across the world, upsurge in the adoption of enteral nutrition, rise in geriatric population, and growth in incidence of malnutrition cases drive the market.

However, stringent governmental regulations and inadvertent dislodgment of tubes leading to accidental disabilities and deaths, impede the market growth.

Conversely, the development of newer products with lesser side effects and presence of untapped market in the emerging economies are expected to provide lucrative growth opportunities for the market.

The enteral feeding pumps segment accounted for the largest share in 2017 owing to growth in usage and lesser side effects as compared to other devices. The enteral syringe segment is expected to grow at the high CAGR from 2018 to 2025.

The neurological disorder segment is the largest application segment in the global enteral feeding device market in 2017 and is estimated to grow at a moderate CAGR during the forecast period. On the other hand, the cancer segment is anticipated to record a highest CAGR during the forecast period.

Key Findings

The enteral feeding tube segment accounted for nearly one-fifth share of the global enteral feeding devices market in 2017 The pediatric segment is expected to grow at a CAGR of 6.5% from 2018 to 2025 The gastrointestinal segment accounted for around one-eighth share of the global market in 2017 North America accounted for around one-third share of the global market in 2017 LAMEA is expected to provide lucrative market growth opportunities and grows with the CAGR of 6% from 2018 to 2025

Company Profiles

Abbott Laboratories Boston Scientific Corporation B. Braun Melsungen AG Becton, Dickinson and Company Danone Fresenius SE & Co. KGaA Halyard Health, Inc. Medtronic Plc. Moog Inc. Nestle S.A.

For more information about this report visit https://www.researchandmarkets.com/research/glrjf9/global_enteral?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180808005620/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Medical Devices



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/08/2018 01:38 PM/DISC: 08/08/2018 01:38 PM


All contents © copyright 2019 The Associated Press. All rights reserved.